Whatever the tools used, any reflection on clinical research must bring us to humility. Indeed, the study results often vary from one study to another, providing contradictory evidence that does little to answer our questions [1, 2] . As for the available tools and methodologies go, they are numerous, each with its own strengths and weaknesses.
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Large multicenter randomized controlled trials (RCTs) are considered the "gold standard" for comparing two treatment strategies. Indeed, the randomization is the only way to balance at random known and unknown or unmeasured confounding factors. The causality in RCTs implies that the initial conditions of randomization remain respected until the assessment of the primary endpoint. Dropout and lack of double-blind interventions, frequently observed in RCTs, are conditions of loss of the exchangeability assumption of RCTs.
But more and more voices are being raised against the hegemony of RCTs [3] . Indeed, not all types of exposure can be randomized. In addition, RCTs are conducted in selected groups which may not be representative of the target population. Furthermore, RCTs only compare precisely defined interventions or exposures, and the results can not be extrapolated to other interventions. This is of importance when the control group is not a faithful mirror of the usual care.
Poor compliance to the assigned treatment is an obvious limitation in determining causal effects in experimental designs. While an "as treated" analysis can be useful, intention-to-treat analysis is preferred but can underestimate causal treatment effect [4] . Replication of the results by an independent randomized trial is mandatory to change practices; however, it is not always available, or feasible. In the setting of critical care medicine, "gold" is expensive and scarce [5] . Can we trust well-conducted and appropriately analyzed high-quality databases or are they simply compilations of clinical observations? We argue for the important role that non-randomized studies can play in clinical research.
Added value of research on clinical databases
Research on clinical databases should not replace RCTs. However, we think it may be instrumental in increasing the level of evidence or raising new hypotheses [6] . This opinion is comforted by the consistency between appropriately analyzed high-quality databases and randomized trials [7] .
First, studies on databases could generate hypotheses about the impact of exposure or of the intervention. Second, by raising the level of uncertainty among clinicians, they can increase the likelihood of clinicians participating in a future RCT. Third, they provide a permanent infrastructure for designing large multicenter trials. Fourth, they can be used to confirm on a general unselected population of patients the generalizability of the results of RCTs which are most often performed in highly selected specialized teaching intensive care units (ICUs). Fifth, by including a larger sample size than RCTs, clinical databases provide an increased statistical power for evaluating patient-oriented outcomes such as mortality, while RCTs often evaluate disease-oriented outcomes [8] .
Good-quality data are available and usable: from big data to high-quality research databases and prospective cohorts
The high-tech ICU generates a considerable amount of data from different data sources on a patient or departmental level [9] . However, these data are captured for many other reasons than research, mainly care, administrative, and cost purposes. The use of administrative databases for research may lead to bias and spurious conclusions. Second, automatic captures of signals from machines may not clearly differentiate artifacts from reliable pieces of information. However, the use of this kind of data is cheap and may be interesting in quickly generating some hypotheses. However, overconfidence in the data reliability, and an incomplete understanding of the underlying relationships, could lead to dubious results and spurious interpretations. Unmeasured confounders, missing data, and inherent noise can generate false positive associations [10] .
In contrast, much data (case-mix, severity, clinical and biological variables, procedure used, etc.) are collected in routine practice and are used in almost all research projects. In intensive care, high-quality research databases already exist and have fueled the discussion in many areas such as vascular filling [11] , sepsis [12] , ARDS, or renal failure [13] . As an example, the OUTCOMEREA network has been using this principle for 20 years to create a high-quality database dedicated only to research purposes and which prospectively captures more than 200 variables each ICU day. Such a database has already been used to answer more than 100 research questions.
Thus the challenge could be to position the decision boundary between a system database adapted for the follow-up and treatment of all patients and a project database dedicated to answering a single clinical research question (Fig. 1) [2] . Projects such as MIMIC II (https ://physi onet.org/mimic 2/, accessed 22 October 2018) in the Beth Israel Deaconess Medical Center in Boston or the EDS built by the Assistance Publique-Hôpitaux de Paris (https ://reche rche.aphp.fr/eds/, accessed 14 October 2018) are to create data marts for research purposes extracted from a data warehouse that contains all the clinical and biological electronic records, examinations, and prescriptions of a given set of patients in numerical, text, or image formats (compiled from all the hospital stays from 40 hospitals in the Parisian area). These projects are ongoing and require precise descriptions and definitions of each variable collected, and careful audits of the data captured before merging and analyses.
Causal inference: how could it be applied to non-randomized studies?
The intrinsic feature of randomized or experimental study design is to provide two or more groups which share the same risk of endpoint before treatment. Therefore, only the allocated intervention differs between groups and thus will influence the outcome, allowing one to draw a causal inference. This may not be the case in non-randomized studies, where the intervention is provided by choice rather than by chance, raising the flag of confounding factors. Confounding is a bias in the estimated measure of association that occurs when the primary exposure of interest is mixed up with some other factors associated with the outcome. In order for confounding to occur, the extraneous factor must be associated with both the primary exposure of interest and the outcome of interest. If the distribution of the extraneous factor is similar in the exposure groups being compared, then this factor will not cause confounding.
Two contemporary statistical methods can be used to approach causal inference: multivariable and propensity score analyses. Both generally yield similar estimates [14] , although the latter confers several advantages. In particular, propensity score methods [15] offer balanced case-mix between groups when the propensity score is used as a matching or weighting variable through the use of standardized difference.
Comparing groups with similar baseline characteristics is necessary but not always sufficient for causal inference. While double-blind randomized design maintains the effect of randomization during follow-up, observational studies are open-label. Therefore, immortal time bias is another very common source of distortion in observational studies [16] . The use of time-dependent exposure in longitudinal cohorts can overcome this problem in the framework of marginal structural models [17] . Of course, all these advanced statistics rely on two strong hypotheses: that unmeasured confounding data and model misspecifications are absent. This means that high-quality database and close collaboration between intensivists and biostatisticians are required [18] .
Conclusion: what should be the position of research using databases in ICU clinical research?
The exploitation of large structured data warehouses of medical patients allows us to identify certain therapeutic strategies and to raise new questions. In the field of pharmacovigilance, registries have been used to identify unexpected side effects which led to changes in the indications or conditions of use of drugs. More recently, in the field of imaging, pneumonia detection algorithms are reportedly challenging the performance of radiologists in the detection of diseases.
High-quality research databases are important tools that may find not only associations but also causal relationships in ICUs. If properly built and carefully maintained, such databases could be used alone in rare diseases, before RCTs in order to generate quantitative hypotheses, and after RCTs to confirm hypotheses and ensure their external generalizability. Fig. 1 From data warehouse to high-quality databases for research. Data sources are now electronically recorded. This considerable amount of data with various structured or unstructured formats and ontologies needs to be integrated into data warehouse using metadata. Metadata is defined as the data providing information about one or more aspects of the data. After integration, these data are organized into data marts easily accessible for many purposes such as research. In this organization structure, the data are not captured for research. Another way to use a data source is to integrate it into high-quality databases devoted to research purposes. This organization directly provides specific variables with precise definition and temporality but requires dedicated personnel, specific training, and careful organization. Both organization structures possess different advantages and pitfalls and may be used as helpful research tools
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